The Technical Analyst
Select Language :
Anika Therapeutics Inc [ANIK]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices

Anika Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Anika Therapeutics Inc is listed at the  Exchange

-0.55% $25.40

America/New_York / 28 mar 2024 @ 16:00


Anika Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 371.88 mill
EPS: -5.64
P/E: -4.50
Earnings Date: May 06, 2024
SharesOutstanding: 14.64 mill
Avg Daily Volume: 0.0853 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -4.50 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.02x
Company: PE -4.50 | industry: PE 222.16
DISCOUNTED CASH FLOW VALUE
$22.70
(-10.62%) $-2.70
Date: 2024-03-29
Expected Trading Range (DAY)

$ 24.32 - 26.48

( +/- 4.25%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Levitz Michael L Buy 51 682 Stock Option (Right to Buy)
2024-03-15 Levitz Michael L Buy 21 329 Restricted Stock Unit
2024-03-15 Colleran David Buy 46 875 Stock Option (Right to Buy)
2024-03-15 Colleran David Buy 19 345 Restricted Stock Unit
2024-03-15 Nunes Anne Buy 26 442 Stock Option (Right to Buy)
INSIDER POWER
51.56
Last 100 transactions
Buy: 1 044 875 | Sell: 338 384

Forecast: 16:00 - $25.35

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $25.35
Forecast 2: 16:00 - $25.35
Forecast 3: 16:00 - $25.35
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $25.40 (-0.55% )
Volume 0.0773 mill
Avg. Vol. 0.0853 mill
% of Avg. Vol 90.68 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Anika Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Anika Therapeutics Inc

RSI

Intraday RSI14 chart for Anika Therapeutics Inc

Last 10 Buy & Sell Signals For ANIK

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:34sell$23.69N/AActive
Profile picture for
            Anika Therapeutics Inc

ANIK

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Last 10 Buy Signals

Date Signal @
HBTCUSDMar 29 - 04:3834 558
DESOUSDMar 29 - 04:3931.41
ARUSDMar 29 - 04:28$41.19
KCSUSDMar 29 - 04:24$11.87
FTNUSDMar 29 - 04:141.819
ORAIUSDMar 29 - 04:0814.59
IONUSDMar 29 - 04:08452.00
MXUSDMar 29 - 04:07$4.21
RETHUSDMar 29 - 04:043 905.62
ABTUSDMar 29 - 04:041.978

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.